Hvis kombinationen af REYATAZ og en protonpumpehæmmer ikke kan undgås, anbefales tæt klinisk monitorering af patienten, samtidig med at dosis af REYATAZ øges til 400 mg med 100 mg ritonavir.
If the combination of REYATAZ with a proton pump inhibitor is judged unavoidable, close clinical monitoring is recommended in combination with an increase in the dose of REYATAZ to 400 mg with 100 mg of ritonavir; doses of proton pump inhibitors comparable to omeprazole 20 mg should not be exceeded.